These symptoms are typically temporary and often diminish as your body adjusts to the medication
These benefits are particularly evident in conditions like nonalcoholic steatohepatitis (NASH), where GLP-1RAs alleviate inflammation and boost insulin sensitivity, leading to improved hepatic glucose management and reduced steatosis (Zheng et al., 2024)
Combining genetic insights with transparent cost comparisons empowers informed conversations with your provider
Flanagan JL, Simmons PA, Vehige J, Willcox MD, Garrett Q (2010) Role of carnitine in disease
This months theme: GLP-1, first coumpound with broad positive effects for longevity
The new BSG & ACPGBI guidance makes it clear: A negative FIT does not rule out GI cancer in IDA Upper GI malignancy risk remains significant Bidirectional endoscopy is still key FIT must not delay investigation in high-risk patients Full guidance in Frontline Gastroenterology: #IDA #FIT #CancerPathways #GIguidelines #FGJournal @British society of gastroenterology @Royal College of Physicians @Oliver Tavabie @benjamin zare @European Society of Gastrointestinal Endoscopy @EASL - The Home of Hepatology @American College of Gastroenterology @American Association for the Study of Liver Diseases (AASLD) @TrevorTabone To view or add a comment, sign in 6,862 followers